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Abstract
Background: Higher walking levels lead to lower mortality in type 2 diabetes, but inclement weather may reduce
walking. In this patient population, we conducted a longitudinal cohort study to objectively quantify seasonal
variations both in walking and in two vascular risk factors associated with activity levels, hemoglobin A1C and
blood pressure.
Methods: Between June 2006 and July 2009, volunteer type 2 diabetes patients in Montreal, Quebec, Canada
underwent two weeks of pedometer measurement up to four times over a one year follow-up period (i.e. once/
season). Pedometer viewing windows were concealed (snap-on cover and tamper proof seal). A1C, blood pressure,
and anthropometric parameters were also assessed. Given similarities in measures for spring/summer and fall/
winter, and because not all participants completed four assessments, spring and summer values were collapsed as
were fall and winter values. Mean within-individual differences (95% confidence intervals) were computed for daily
steps, A1C, and systolic and diastolic blood pressure, by subtracting spring/summer values from fall/winter values.
Results: Among 201 participants, 166 (82.6%) underwent at least one fall/winter and one spring/summer
evaluation. Approximately half were women, the mean age was 62.4 years (SD 10.8), and the mean BMI was
30.1 kg/m
2 (SD 5.7). Step counts averaged at a sedentary level in fall/winter (mean 4,901 steps/day, SD 2,464) and
at a low active level in spring/summer (mean 5,659 steps/day, SD 2,611). There was a -758 (95% CI: -1,037 to -479)
mean fall/winter to spring/summer within-individual difference. There were no significant differences in A1C or in
anthropometric parameters. Systolic blood pressure was higher in fall/winter (mean 137 mm Hg, SD 16) than
spring/summer (133 mm Hg, SD 14) with a mean difference of 4.0 mm Hg (95% CI: 2.3 to 5.7).
Conclusions: Daily step counts in type 2 diabetes patients are low, dipping lower during fall/winter. In this
medication-treated cohort, A1C was stable year-round but a fall/winter systolic blood pressure increase was
detected. Our findings signal a need to develop strategies to help patients increase step counts year-round and
prevent both reductions in step counts and increases in blood pressure during the fall and winter.
Background
Diabetes patients have a two to four-fold increased risk
for cardiovascular disease compared to the general
population [1-3]. Even among those with established
diabetes higher activity levels predict lower vascular dis-
ease rates and improved survival; walking has been spe-
cifically proven to confer benefits. For example, in the
National Health Interview Survey, adults with diabetes
who reported walking more than two hours per week
had a 34% reduction in vascular events up to 14 years
later compared to those walking less [4]. Similarly, in
the Nurses’ Health Study, women with diabetes in the
highest quartile for self-reported walking were 34% less
likely to have died up to 8 years later compared to
women in the lowest quartile [5]. Although more than
50% of diabetes patients report a preference for walking
over other forms of physical activity [6], walking is
underutilized by these patients [7]. It is therefore impor-
tant to examine barriers to walking in diabetes patients,
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walking levels.
In temperate climates, the lower temperatures and
precipitation characteristic of fall and winter may
impede walking. To examine the importance of season
as a determinant of walking in diabetes patients, we
conducted a longitudinal cohort study examining ped-
ometer-measured “daily steps” over a one year follow-up
period. In addition to assessing for seasonal variations in
daily steps, we were interested in measuring any seaso-
nal changes in glycemic control and in blood pressure,
two vascular risk factors that may be impacted by physi-
cal activity levels. Studies from Japan [8,9], China [10],
Sweden [11], the United Kingdom [12], and the United
States [13] suggest that post winter A1C values may be
0.13% to 0.6% higher than summer values and, in non-
diabetic populations, higher blood pressure has been
reported during the fall/winter months [14-16]. No pre-
vious study has concurrently examined for seasonal dif-
ferences in both physical activity levels and vascular risk
factors.
Methods
Our study was conducted in Montreal, Quebec, Canada,
a city with a humid continental climate and abundant
winter snowfall. Specifically, between 1971 and 2000,
the mean temperature in Montreal by season was
respectively:-8.3°C (SD 3.0°C) for winter, 5.6°C (SD
1.9°C) for spring, 19.6°C (SD 1.1°C) for summer, and
8.1°C (SD 1.5°C) for fall. Over this period, the mean
cumulative precipitation (rain and snow) by season
was respectively: 221.1 mm (SD 32.8 mm) for winter,
227.9 mm (SD 32.0 mm) for spring, 267.1 mm (SD 35.0
mm) for summer, and 263.0 mm (SD 39.7 mm) for fall.
Previously published [17], our study design and meth-
ods are summarized here. Our original goals were to
estimate the post winter to summer change in glucose
control (i.e. spring to fall A1C difference); determine
w h e t h e rt h i sc h a n g ei sa n t e d a t e db yaw i n t e rt os p r i n g
change in walking; and to determine whether the winter
to spring change in walking differs between men and
women. Although blood pressure assessments were not
detailed in our published protocol [17], we opted to
examine systolic and blood pressure seasonal variations
as a secondary outcome, given previous studies in non-
diabetic populations demonstrating such variations
[14-16]. Further, given the similarity of data from spring
and summer and from fall and winter, we have per-
formed analyses combining data from spring and sum-
mer and from fall and winter, so as to maximize the
precision of our estimates.
Procedures were approved by the Institutional Review
Boards (IRB) of McGill University and participating
institutions (McGill University Health Centre, Sir
Mortimer Davis Jewish General Hospital, Centre de
Santé et de Services Sociaux de la Montagne). Recruit-
ment was conducted through clinics and local diabetes
associations using posters, presentations, and clinic staff
referrals. Candidates required a physician diagnosis of
type 2 diabetes. To permit accurate pedometer-based
measurement, a body mass index (BMI) less than 40 kg/
m
2 and a normal gait [18] were necessary. If stable, the
presence of other chronic conditions was not an exclu-
sion criterion. After providing informed consent, partici-
pants were asked to present once per season to the
study centre over a one-year period. Venous blood was
sampled for A1C measurement (Bio-Rad Variant II sys-
tem) and blood pressure (15-minute rest; left arm;
Omron HEM 747 IC) and anthropometric parameters
were directly assessed (weight, using SECA 882 electro-
nic scale; height, using SECA 214 stadiometer; and waist
and hip circumferences).
Yamax SW-701 pedometers were used to measure
step counts. At all assessments, participants were pro-
vided with three pedometers as well as a padded, pre-
addressed, pre-stamped envelope. The pedometer view-
ing windows were concealed with snap-on covers and
tamper-proof seals to reduce the likelihood that partici-
pants would alter their behaviour in response to the
step count value recorded. Participants were instructed
to wear Pedometer A for one week, Pedometer B for a
second week, and then mail back these pedometers
along with Pedometer C, which served to capture the
“postman steps” that occur during the mailing process.
The step counts recorded on Pedometers A and B were
corrected by subtracting those recorded on Pedometer
C. Corrected values were then summed and divided by
the total number of days the two pedometers had been
worn (usually 14 days) for an estimate of steps/day. As
per the classification scheme proposed by Tudor-Locke
and Bassett, step counts may be used to categorize indi-
viduals as “high active” (> 12,500 steps/day), “active”
(10,000 to 12, 499 steps/day), “somewhat active” (7,500
to 9,999 steps/day), “low active” (5,000 to 7,499 steps/
day) or “sedentary” (< 5,000 steps/day) [19].
In addition to this direct assessment of daily steps, we
also administered the short form of the International
Physical Activity Questionnaire (last 7 days) which
allowed for computation of self-reported total physical
activity (metabolic equivalent-minutes/week) [20]. Parti-
cipants were administered the Food Frequency Ques-
tionnaire (FFQ) developed by Shatenstein and colleagues
and previously validated using four non-consecutive 1-
day food records [21]; data from the FFQ provided esti-
mates of both carbohydrate and salt intake, which may
respectively impact glycemic and blood pressure control.
Assuming a maximum standard deviation (SD) of
5,000 steps/day, a sample of 80 individuals was deemed
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ence to within +/- 1,100 steps or better using a 95%
confidence interval. Additionally, using a maximum SD
of 0.94% for A1C values as suggested by a limited num-
ber of previous studies [9,12,13], a sample of 152 indivi-
duals was deemed adequate to permit an estimate of
between-season A1C differences within +/- 0.15% using
a 95% confidence interval. In order to capture both
potential between-season differences in daily steps and
A1C, and to allow for the possibility of dropouts in a
longitudinal study, we aimed to recruit approximately
200 subjects.
Participant characteristics were summarized using
means, standard deviations, medians, interquartile
ranges, and proportions, as appropriate. Fall was defined
as September-November; winter as December-February;
spring as March-May; and summer as June-August.
Mean values across individuals were plotted for daily
steps, self-reported physical activity, anthropometric
parameters, A1C, and blood pressure. With respect to
the original study aims, the post winter to summer dif-
ference in glycemic control was computed by subtract-
ing the fall A1C (i.e. reflective of summer glycemic
control) from the spring A1C (i.e. reflective of winter
glycemic control). The winter to spring difference in
daily steps was computed by subtracting the spring daily
steps from those in winter, for men and women sepa-
rately and combined.
With respect to the analyses that involved combining
fall with winter and spring with summer values, spring/
summer values were subtracted from the fall/winter
values (fall/winter-spring/summer difference) for each
participant with respect to daily steps, A1C, systolic and
diastolic blood pressure, body mass index, self-reported
physical activity, and carbohydrate and salt intake. Addi-
tionally, for A1C, summer/fall values (i.e. reflective of
spring/summer glycemic control and habits) were sub-
tracted from winter/spring values (i.e. reflective of fall/
winter glycemic control).
For each variable, differences were averaged and 95%
CIs were computed. Mean differences were not further
adjusted as these were mean within-individual differ-
ences and thus each participant served as his/her own
control. We performed sensitivity analyses which
included only those participants without changes in the
number of antihypertensive or antihyperglycemic medi-
cations. Associations of step count differences with clini-
cally important differences in other variables were
examined through multivariate linear regression: keeping
our primary variable (daily step count difference) in each
model, we assessed confounding by comparing the beta-
coefficient for daily step count difference as potential co-
variates and confounders entered and exited the models.
Results
A total of 201 participants were recruited between June
2006 and June 2008 and final evaluations were completed
by July 2009. Participant retention remained above 80%
by the third visit but fell to slightly under 70% by the
fourth visit (Figure 1). Among a total of 687 visits, 164
occurred in winter (23.8%), 170 in spring (24.7%), 173 in
summer (25.1%), and 180 in fall (26.2%). One hundred
and sixty-six participants (82.6%) were evaluated at least
once during both fall/winter and spring/summer periods.
Among the remaining 35 individuals, reasons for not pre-
senting for at least a second visit included lack of interest
(46%), distance from study centre (3%), family illness
(3%), moving/travel (9%), unstable co-morbid illness or
diabetes other than type 2 (11%), or was unspecified.
These participants did not differ importantly from the
166 retained in our fall/winter vs. spring/summer ana-
lyses (Table 1). For the years included in our study, all
seasonal mean temperatures were within one standard
deviation of usual seasonal mean temperatures (see
Methods) but precipitation was above average levels for
several seasonal periods (i.e. 316.2 mm for Fall 2006,
278.6 mm for spring 2007, 325.8 mm for winter 2008,
and 304.9 mm for winter 2009).
Roughly equal numbers of women and men were
recruited and participants were, on average, middle aged
to elderly with an overweight to obese BMI. Fewer than
10% smoked cigarettes. Mean A1C and blood pressure
values were slightly above usual treatment targets.
Nearly one third used insulin and over three quarters
used a statin. Over one quarter were non-White and
over 40% were immigrants. Roughly 40% were univer-
sity-educated. Less than one fifth had a past history of
vascular disease. The Pearson correlation coefficient for
pedometer A and B values was 0.70 with a 95% confi-
dence interval of 0.65 to 0.73. Subtracting pedometer A
from B values, the average difference was -166 steps/day
(95% confidence interval: -347 to 14 steps/day), suggest-
ing slightly higher step counts during the first week of
each two-week pedometer measurement period. Daily
step counts were in the sedentary to low active range,
on average, as per the classification scheme proposed by
Tudor-Locke and Bassett [19]. Plots of variables by sea-
son suggested lower step counts and self-reported physi-
cal activity in the fall and winter as well as higher
systolic blood pressure levels (Figure 2).
With respect to the original study aims, the spring
minus fall difference in A1C was 0.12% with a 95% confi-
dence interval of -0.04% to 0.28%. The difference was thus
in the anticipated direction (i.e. higher spring A1C than
fall indicating higher glucose levels in winter than sum-
mer) but the confidence interval does not exclude an
absence of difference. When analyses were restricted to
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medications, the spring minus fall differences in A1C was
still 0.12% with a 95% CI of 0 to 0.25%. Participants
walked an average of 777 steps/day more in the spring
than in the winter (95% CI 408 to 1,145 steps/day). The
daily step difference was similar in men and women. Men
walked an average of 581 steps/day more in the spring
than in the winter (95% CI 7 to 1,170 steps/day) while
w o m e nw a l k e da na v e r a g eo f9 8 4s t e p s / d a ym o r ei nt h e
spring than in the winter (95% CI 540 to 1.428 step/day).
When seasons were combined to increase the preci-
sion of estimates, no clinically important differences in
A1C or anthropometric parameters were detected
(Table 2). Participants completed 758 fewer steps/day in
the fall/winter compared to the spring/summer (95% CI
479 to 1,037 steps/day). Like step counts, self-reported
physical activity was also lower in the fall/winter than
spring/summer, with 450 MET-minutes/week fewer in
the fall/winter (95% CI 30.4 to 872 MET-minutes/week).
Additionally, systolic blood pressure was 4.0 mm Hg
higher in the fall/winter period than in the spring/sum-
mer period (95% CI 2.3 to 5.7 mm Hg) and diastolic
blood pressure was 1.4 mm Hg higher (95% CI 0.4 to
2.4 mm Hg). Salt intake may have been slightly higher
in fall/winter than in spring/summer (51.9 mg/day, 95%
CI -86.3 to 190 mg/day) but confidence intervals were
wide. There were no clinically important differences in
total energy intake or anthropometric parameters.
The fall/winter -spring/summer daily step difference
was similar in women (-734 steps/day, 95% CI -1,079 to
-388) and men (-781 steps/day, 95% CI -1,222 to -341).
The fall/winter - spring/summer self-reported total phy-
sical activity difference was also similar in women and
men but confidence intervals were wide in sex-specific
analyses. The difference in systolic blood pressure was
similar in women (4.5 mm Hg, 95% CI 2.1 to 6.8 mm
Hg) and men (3.5 mm Hg, 95% CI: 0.9 to 6.1). We
could not, however, conclusively establish that the fall/
winter increase in systolic blood pressure detected was
attributable to the fall/winter reduction in daily steps.
When analyses were restricted to the 118 individuals
who did not experience a change in the number of anti-
hypertensive medications between winter and summer,
the overall winter-summer difference in systolic blood
pressure remained (4.1 mm Hg, 95%: CI 1.3 to 6.9).
Discussion
Through a longitudinal cohort study, we have demon-
strated a 15% reduction in daily steps, a 4.0 mm Hg
increase in systolic blood pressure, and a 1.4 mm Hg
increase in diastolic blood pressure during the fall and
winter months among overweight adults treated for type
2 diabetes. However, no clinically important seasonal
variations in A1C were identified. The magnitude of
ParticipantsEnrolled
N=201
Visit1
N=201
39(19.4%) Winter
53(26.4%) Spring
41(20.4%) Summer
68(33.8%) Fall
Visit2
N=180(90.1%)
51(28.3%) Winter
40(22.2%) Spring
49(27.2%) Summer
40(22.2%) Fall
Visit3
N=167(83.1%)
35(21.0%) Winter
51(30.5%) Spring
38(22.8%) Summer
43(25.7%) Fall
Visit4
N=139(69.2%)
39(28.1%) Winter
26(18.7%) Spring
45(32.4%) Summer
29(20.9%) Fall
Figure 1 Participant flow.
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cient to explain the corresponding fall/winter increase in
blood pressure, suggesting that other seasonal factors
impact blood pressure. Nonetheless, both the 15%
reduction in daily steps and the blood pressure increase
m a ya r g u a b l yh a v eal o n gt e r mi m p a c to nv a s c u l a r
health, particularly as these may recur annually.
With respect to daily step counts, our participants in
fact demonstrated low daily step counts throughout the
year. Specifically, average daily step counts were 5,659
Table 1 Baseline characteristics
Total N = 201 Both Fall/Winter and Spring/Summer Data N =
166
Women, % 46.8 48.8
Age, years, mean (SD) 62.2 (10.5) 62.4 (10.8)
Diabetes, years, median (IQR) 8 (3 to 13) 8 (3 to 13)
Married/common-law,% 68.9
a 68.6
White, % 69.2 69.3
Immigrant, % 46.3 44.6
Education, %
High school 24.8 24.7
College 22.4 21.7
University 38.8 40.4
Depressed mood, %
b 27.4 25.3
Current smoking, % 9.5
a 9.7
Cardiovascular Disease % 16.9 18.7
Physical activity
Walking, steps/day, mean (SD) 5,365 (2,655) 5,308 (2,477)
Self-reported total activity, metabolic equivalent-minutes/week,
median (IQR)
c
1,965
d (777 to
3,450)
1,965
e (849 to 3,417)
Anthropometric measures, mean (SD)
BMI, kg/m
2 30.4 (5.6) 30.1 (5.7)
Waist circumference, cm
Women 99.2 (12.9) 98.6 (13.6)
Men 104.5 (12.9) 103.7 (13.0)
Waist/hip
Women 0.88 (0.07) 0.88 (0.06)
Men 0.97 (0.06) 0.96 (0.06)
Intake, median (IQR)
f
Total energy, kcal/day 1,676 (1,770 to
2,089)
1,723 (1,256 to 2,171)
Carbohydrates, g/day 177 (125 to 232) 180 (126 to 243)
Salt, mg/day 2,348 (1,569 to
3,103)
2,414 (1,699 to 3,225)
A1C, mean (SD) 7.6 (1.4) 7.6 (1.4)
Antihyperglycemics, median (IQR) 2 (1 to 2) 2 (1 to 2)
Insulin, % 32.8 34.9
Blood Pressure, mm Hg, mean (SD)
Systolic 138 (17) 137 (17)
Diastolic 80 (11) 81 (10)
Antihypertensives, median (IQR) 2 (1 to 3) 2 (1 to 3)
Statin, % 77.6 75.9
SD, standard deviation; IQR, interquartile range
a N = 180 because assessed at second visit
b Center for Epidemiological Studies-Depression Scale with score above 16 indicated depressed mood
c International Physical Activity Questionnaire (Short Last 7 days format) [20]
d N = 167 who provided sufficient data for computation
e N = 137 who provided sufficient data for computation
f Shatenstein and colleagues’ Food Frequency Questionnaire [21].
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4,901during the fall/winter period, with a mean fall/win-
ter to spring/summer within-individual difference of
-758 (95% CI: -1,037 to -479). The 758 steps/day
reduction that we have identified is consistent with data
from nondiabetic samples, including a 900 steps/day
reduction in an American study [22] and a 1,300 steps/
d a yr e d u c t i o ni naB r i t i s hs t u d y[ 2 3 ] .Ad a i l ys t e p
Figure 2 Seasonal patterns in step counts (A), self-reported activity (B), blood pressure (C), anthropometric measures (D, E), and
hemoglobin A1C (F). Mean values with 95% confidence intervals indicated by broken lines. SBP, systolic blood pressure; A1C, hemoglobin A1C.
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ably of particular significance given the high risk for vas-
cular complications in this clinical population [1-3]
combined with the survival benefits of higher activity
levels[4,5].
With respect to A1C levels, the between-season and
between-period differences that we identified were in
the order of 0.1% with wide confidence intervals: our
study was powered to detect differences of 0.2% or
more. While we cannot conclusively exclude the exis-
tence of a between-season difference, such a 0.1% differ-
e n c ew o u l da r g u a b l yb eo fq u e s t i o n a b l ec l i n i c a l
importance. Our finding of relatively stable A1C levels
contrasts with some previous reports [9,12,13]. Unlike
these previous studies, we assessed average differences
within individuals rather than across individuals; such
within-individual differences may be less marked.
Further, stability of A1C levels may also have resulted
from the fact that this was a treated clinical population
specifically managed for type 2 diabetes and thus subject
to careful titration of antihyperglycemic medication.
Moreover, given that these individuals volunteered to
participate in an observational cohort study, they may
have been somewhat more diligent in their diabetes self-
management than other diabetes patients.
In contrast, we did detect a fall/winter systolic blood
pressure increase, despite the possibility of more careful
self-management. Fall/winter was associated with an
increase in systolic blood pressure levels of 4.0 mm Hg
(95% CI: 2.3 to 5.7) and an increase in diastolic blood
pressure of 1.4 (0.4 to 2.4). In other populations, fall/
winter increases in systolic blood pressure have been
reported at roughly 2 to over 5 mm Hg [15,16]. The
increase that we have detected is consistent with these
values. The importance, however, of such a blood pres-
sure increase is arguably greater in adults with diabetes.
The United Kingdom Prospective Diabetes Study
(UKPDS) [24], and more recently, the Action in Dia-
betes and Vascular Disease (ADVANCE) trial [25], have
demonstrated the particular importance of lower blood
pressure levels in patients with type 2 diabetes. In the
UKPDS, each 10 mm Hg reduction in systolic blood
pressure was associated with a 15% lower mortality and
an 11% lower heart attack rate. The systolic blood pres-
sure lowering that we have detected in spring/summer
represents approximately one third of such a 10 mm Hg
reduction. In ADVANCE, treatment with perindopril/
indapamide was associated with a mean systolic blood
pressure reduction of 5.6 mm Hg and a 9% reduction in
CVD events. The systolic blood pressure lowering that
we have detected in spring/summer is therefore equiva-
lent to more than half of the systolic blood pressure
r e d u c t i o ni nt h eA D V A N C Et r i a l .P r e v e n t i n ge v e na
small recurrent annual blood pressure increase in fall/
Table 2 Fall/Winter to Spring/Summer Differences
Fall/Winter, mean (SD)
across individuals
Spring/Summer, mean (SD)
across individuals
Within-Individual Fall/Winter to Spring/
Summer Differences (95% CI)
Objective measures
Walking, steps/day 4,901 (2,464) 5,659 (2,611) -758 (-1,037 to -479)
Hemoglobin A1C
a, % 7.6 (1.3) 7.7 (1.3) -0.10 (-0.21 to 0)
Systolic blood pressure, mm Hg 137 (16) 133 (14) 4.0 (2.3 to 5.7)
Diastolic blood pressure, mm Hg 80 (10) 79 (9) 1.4 (0.4 to 2.4)
BMI, kg/m
2 30.2 (6.0) 30.2 (6.0) 0.07 (-0.04 to 0.18)
Waist circumference, cm
Women 98.7 (14.1) 98.9 (13.8) -0.2 (-1.0 to 0.5)
Men 104.2 (13.0) 104.8 (12.7) -0.5 (-1.3 to 0.2)
Waist/hip
Women 0.879 (0.063) 0.882 (0.061) -0.003 (-0.01 to 0.004)
Men 0.967 (0.060) 0.971 (0.060) -0.004 (-0.01 to 0.004)
Self-reported measures
Total energy intake, kcal/day
b 1,730 (684) 1,700 (662) 30.0 (-37.9 to 98.0)
Carbohydrate intake, g/day
b 187 (76) 182 (74) 5.7 (-2.9 to 14.4)
Salt intake, mg/day
b 2,598 (1353) 2,546 (1182) 51.9 (-86.3 to 190)
Total physical activity, metabolic
equivalent-minutes/week
c
2,598 (2463) 2,921 (2700) -451 (-872 to -30.4)
SD, standard deviation; CI, Confidence interval
a Given that A1C reflects glycemic control over the prior two to three months, winter/spring A1C values may reflect fall/winter glycemic control and summer/fall
A1C values may reflect spring/summer glycemic control. We therefore also computed Winter/spring to Summer/Fall difference in A1C which was 0.012% (95% CI
-0.10% to 0.13%).
b Shatenstein and colleagues’ Food Frequency Questionnaire [21]
c International Physical Activity Questionnaire (Short Last 7 days format) [20]
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tially result in cumulative vascular damage over time.
The large fall/winter-spring/summer difference in
blood pressure that we detected could not be explained
by the magnitude of the fall/winter-spring/summer daily
step difference that we observed. Similarly, correspond-
ing differences in anthropometric parameters and salt
intake (Table 2) were not sufficient to account for the
blood pressure difference. Alternate potential contribu-
tory factors may be a direct impact of cold temperatures
on blood pressure [26,27], lower sunlight exposure and
reduced vitamin D production in fall/winter [28], or
acute illnesses such as influenza.
The average 758 daily step reduction did not lead to
seasonal increases in A1C in our cohort and did not
account for the mean 4.0 mm Hg systolic blood pres-
sure increase in fall and winter. This should not, how-
ever, deter clinicians from encouraging their patients to
increase their step counts as a means of lowering both
A1C and blood pressure. In one interventional study
conducted among type 2 diabetes patients, for example,
an increase in daily steps of more than 2,300 steps/day
led to a 0.3% reduction in A1C [29]. Furthermore, in a
previously-reported analysis of our cohort aiming to
cross-sectionally assess associations between habitual
daily step counts and systolic blood pressure, we identi-
fied an inverse relationship between daily steps and
blood pressure among women treated for diabetes [30].
Specifically, a 1,000 daily step increment among women
was conclusively related to a -2.6 mm Hg change in sys-
tolic and a -1.4 mm Hg change in diastolic blood pres-
sure. Among men, changes were signalled but were
smaller and inconclusive (-0.7 and -0.6 mm Hg, respec-
tively). Given the potential for impact of higher daily
steps on A1C, blood pressure, and long term mortality
[4,5], the low habitual daily step counts and fall/winter
reduction that we have quantified in the present paper
signal a need for action
Targeting daily step counts in type 2 diabetes has been
the focus of a previous Canadian trial, Tudor-Locke’s
First Step program [31]. In this trial, group meetings
and pedometer-based self-monitoring was successful in
achieving a 3,000 daily step increase at 16 weeks but
between-group differences were not sustained at longer
term follow-up following the intervention period. There
thus appears to be a need for ongoing monitoring and
encouragement, ideally through a strategy that is better
integrated into routine clinical care. Our own discus-
sions with adults with type 2 diabetes indicate a need
for such long term support [32]. In this regard, the phy-
sician-patient relationship is a logical potential source of
such support, given the continuing association. Follow-
up of pedometer-based self-monitoring records would
be highly compatible with existing systems of diabetes
care, wherein, for example, patient records of capillary
glucose monitoring and home blood pressure measure-
ments are often reviewed and accounted for in medica-
tion titration. Our quantification of daily steps and fall/
winter reductions provides a framework for discussion
and monitoring.
We acknowledge some limitations. The repeated visits
in the context of an observational cohort study required
particularly dedicated volunteers who may not be repre-
sentative of all diabetes patients. However, we would
argue that other patients are thus likely to have even
lower daily step counts and greater fall/winter step
count reductions and blood pressure increases. A sec-
ond potential limitation is that blood pressure values
were only assessed once per visit and thus the overall
levels reported may be higher than if serial measure-
ments had been averaged. However, a standard proce-
dure was followed and thus between visit differences
were likely accurate. Strengths of our study include the
examination of within-individual comparisons, preclud-
ing the need for further adjustments.
Conclusions
Our observational cohort study is the largest longitudinal
study to assess daily step counts in type 2 diabetes. Step
counts averaged at the sedentary level in fall/winter
(mean 4,901 steps/day, SD 2,464) and at the low active
level in spring/summer (mean 5,659 steps/day, SD 2,611).
There was a -758 (95% CI: -1,037 to -479) mean fall/win-
ter to spring/summer within-individual difference.
Although no important seasonal difference in A1C was
detected, there was a 4.0 mm Hg systolic blood pressure
increase and a 1.4 mm Hg diastolic blood pressure
increase during the fall/winter period. This information,
in conjunction with the existing body of evidence sup-
porting pedometer-based strategies, may be used by clini-
cians in setting step count targets with their patients and
preventing both fall/winter declines in step counts and
increases in blood pressure. For these reasons, our find-
ings bring to light an opportunity for a pre-emptive
approach to vascular risk reduction in type 2 diabetes.
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